Fanzhu Q. Li
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Coordination-based nanocomposite hydrogel promotes tissue regeneration under infection-compromised conditions.
Journal: Regenerative biomaterials
Published: January 02, 2026
Correction: Chen et al. Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation. Pharmaceutics 2025, 17, 614.
Journal: Pharmaceutics
Published: November 28, 2025
The Advances in Novel Delivery Strategies for Hirudin Against Cardiovascular Diseases.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 22, 2025
A Biomimetic Macrophage-Membrane-Fused Liposomal System Loaded with GVs-HV Recombinant Plasmid for Targeted Anti-Atherosclerosis Therapy.
Journal: Pharmaceutics
Published: October 21, 2025
Biomimetic strategies of cell membrane vesicles driven by pathogen-host interactions: novel insights into antimicrobial immunotherapy and infection prevention.
Journal: Frontiers in immunology
Published: August 08, 2025
Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation.
Journal: Pharmaceutics
Published: April 04, 2025
Immune metabolic restoration in systemic lupus erythematosus: the impact of gut microbiota, probiotics, and nutritional synergy.
Journal: Frontiers in immunology
Published: March 29, 2025
Co-Delivery of Dacarbazine and miRNA 34a Combinations to Synergistically Improve Malignant Melanoma Treatments.
Journal: Drug design, development and therapy
Published: October 21, 2024
Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy.
Journal: Asian journal of pharmaceutical sciences
Published: May 18, 2024
Shape Matters: Impact of Mesoporous Silica Nanoparticle Morphology on Anti-Tumor Efficacy.
Journal: Pharmaceutics
Published: April 17, 2024
A self-assembly active nanomodulator based on berberine for photothermal immunotherapy of breast cancer via dual regulation of immune suppression.
Journal: International journal of pharmaceutics
Published: November 30, 2023
Strategies to Regulate the Degradation and Clearance of Mesoporous Silica Nanoparticles: A Review.
Journal: International journal of nanomedicine
Published: November 27, 2023
Last Updated: 09/26/2026